MTOR and cancer: Numerous studies have shown the association between PLCE1 and PI3K/AKT/mTOR signaling during inflammation-association carcinogenesis [44], thus targeting PI3K/AKT/mTOR-mediated inflammatory pathway could be a good strategy for cancer prevention and therapy [45].